MARSHALL WACE, LLP - EPIPHANY TECHNOLOGY ACQUISIT ownership

EPIPHANY TECHNOLOGY ACQUISIT's ticker is EPHY and the CUSIP is 29429X109. A total of 50 filers reported holding EPIPHANY TECHNOLOGY ACQUISIT in Q4 2022. The put-call ratio across all filers is 55.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of EPIPHANY TECHNOLOGY ACQUISIT
ValueSharesWeighting
Q3 2022$18,776,000
+32.8%
1,900,419
+32.0%
0.04%
+41.4%
Q2 2022$14,140,000
+2.2%
1,439,882
+2.2%
0.03%
+11.5%
Q1 2022$13,841,000
+0.7%
1,409,542
+0.1%
0.03%
+4.0%
Q4 2021$13,750,000
+68.4%
1,408,822
+68.5%
0.02%
-26.5%
Q3 2021$8,167,000835,9110.03%
Other shareholders
EPIPHANY TECHNOLOGY ACQUISIT shareholders Q4 2022
NameSharesValueWeighting ↓
Hawkeye Capital Management, LLC 632,138$6,208,0002.45%
RP Investment Advisors LP 1,100,000$10,802,0001.51%
HGC Investment Management Inc. 1,715,000$16,842,0001.01%
Sage Rock Capital Management LP 359,298$3,528,0000.63%
MMCAP International Inc. SPC 1,000,000$9,820,0000.57%
Saba Capital Management, L.P. 2,816,395$27,657,0000.39%
CVI Holdings, LLC 568,882$5,586,0000.37%
Castle Creek Arbitrage, LLC 728,652$7,148,0000.36%
ARISTEIA CAPITAL, L.L.C. 2,011,452$19,752,0000.36%
BASSO CAPITAL MANAGEMENT, L.P. 373,790$3,671,0000.35%
View complete list of EPIPHANY TECHNOLOGY ACQUISIT shareholders